Back

Longitudinal characterization of clinically relevant haemodynamics in conscious Ossabaw pigs with HFpEF

27 August 2022 (14:15 - 15:00)
Organised by:
Congress Presentation Part of: Heart failure with preserved ejection fraction (HFpEF) 1 Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Jakob Balitzki

Bayer AG, Wuppertal (Germany)

6 More presentations in this session

Presentation thumbnail
Low-dose dopamine improves ventilatory efficiency during exercise in heart failure with preserved ejection fraction through inhibition of tonic activity of peripheral chemoreceptors
Mrs K. Kulej-Lyko (Wroclaw, PL)
Abstract Slides
Presentation thumbnail
Cardiopulmonary response to exercise and heart failure with preserved ejection fraction risk: a comparative analysis of HFA-PEFF and H2FPEF scores
Doctor D. Lazzeroni (Parma, IT)
Abstract Slides
Presentation thumbnail
A clinical and echocardiographic score to differentiate pulmonary hypertension due to heart failure with preserved ejection fraction from idiopathic pulmonary hypertension: the PH-HFPEF score
Doctor A. Ballerini (Bologna, IT)
Abstract Slides
Presentation thumbnail
Association between prognosis and the use of angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blocker in frail patients with heart failure with preserved ejection fraction
Doctor A. Sunaga (Suita, JP) Professor S. Hikoso (Nara, JP)
Abstract Slides
Presentation thumbnail
A meta-analysis of exercise hemodynamics in heart failure with preserved ejection fraction: the relevance of PAWP/CO slope
Doctor C. Baratto (Bergamo, IT)
Abstract Slides

Access the full session

Session thumbnail
Heart failure with preserved ejection fraction (HFpEF) 1

The Event

Event poster

ESC Congress 2022

27 August 2022 14:15 CET
You may be interested in
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Mitral regurgitation, atrial fibrillation, and HFpEF: a three-headed dragon
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources